Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients

Abstract

Background: Antibodies against aquaporin-4 (AQP4), a water channel particularly expressed on perivascular astrocytic podocytes, are proposed as a marker for the diagnosis of neuromyelitis optica (NMO). However, a consensus on seroprevalence and optimal detection method has not yet been reached.

Objectives: To investigate the performance of different assays to detect anti-AQP4 antibodies.

Methods: We set up five different assays. Two of them were capable to detect perivascular IgG reactivity on brain tissue by immunofluorescence (NMO-IgG). Other three assays have been set to detect anti-AQP4 antibodies: immunofluorescence and flow cytometry on AQP4-expressing cells, and a radioimmunoprecipitation assay. We assessed sensitivity and specificity of these assays by interrogating sera of 33 NMO patients, 13 patients at high risk to develop NMO (hrNMO), 6 patients affected by acute partial transverse myelitis (APTM), 20 patients with multiple sclerosis (MS), and 67 age- and sex-matched healthy controls.

Results: We found that the presence of serum NMO-IgG and anti-AQP4 reactivity is almost exclusively restricted to patients with NMO and hrNMO. Seroprevalence and sensitivity ranged from 30 to 47%, depending on the assay. Specificity ranged from 95 to 100%. Comparing results obtained in the five assays, we noticed lack of concordance in some samples.

Conclusions: Detection of NMO-IgG or anti-AQP4 antibodies may represent a valuable tool to assist neurologists in the differential diagnosis between patients with NMO, hrNMO, APTM, or MS. The current lack of a gold standard to detect anti-AQP4 antibodies implies the necessity to standardize the detection of these antibodies.

Keywords

Neuromyelitis optica

Get full access to this article

View all access options for this article.

References

Wingerchuk DM , Hogancamp WF , O’Brien PC , Weinshenker BG The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology 1999; 53: 1107-1114.

Wingerchuk DM , Lennon VA , Pittock SJ , Lucchinetti CF , Weinshenker BG Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-1489.

Ghezzi A. , Bergamaschi R. , Martinelli V. , et al. Italian Devic’s Study Group (IDESG). Clinical characteristics, course and prognosis of relapsing Devic’s Neuromyelitis Optica. J Neurol 2004; 251: 47-52.

Wingerchuk DM , Weinshenker BG Neuromyelitis optica. Curr Treat Options Neurol 2005; 7: 173-182.

Lennon VA , Wingerchuk DM , Kryzer TJ , et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106-2112.

Lennon VA , Kryzer TJ , Pittock SJ , Verkman AS , Hinson SR IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005; 202: 473-477.

Jarius S. , Paul F. , Franciotta D. , et al. Revised diagnostic criteria for neuromyelitis optica-incorporation of NMOIgG status. Nat Clin Pract Neurol 2007 ; 3: E1.

Nakashima I. , Fujihara K. , Miyazawa I. , et al. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 2006; 77: 1073-1075.

Paul F. , Jarius S. , Aktas O. , et al. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica . PLoS Med 2007; 4: e133.

10.

Wingerchuk DM , Lennon VA , Lucchinetti CF , Pittock SJ , Weinshenker BG The spectrum of neuromyelitis optica. Lancet Neurol 2007; 6: 805-815.

11.

McKeon A. , Lennon VA , Lotze T. , et al. CNS aquaporin-4 autoimmunity in children . Neurology 2008; 71: 93-100.

12.

Waters P. , Vincent A. Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays. Int MS J 2008; 15: 99-105.

13.

Matsuoka T. , Matsushita T. , Kawano Y. , et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 2007; 130: 1206-1223.

14.

Takahashi T. , Fujihara K. , Nakashima I. , et al. Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica. Tohoku J Exp Med 2006; 210: 307-313.

15.

Jarius S. , Aboul-Enein F. , Waters P. , et al. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 2008; 131: 3072-3080.

16.

Apiwattanakul M. , McKeon A. , Fryer JP , Hinson SR , Pittock SJ , Lennon VA AQP4-IgG immunoprecipitation assay optimization . Clin Chem 2009; 55: 592-594.

17.

Barkhof F. , Filippi M. , Miller DH , et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997; 120(Pt 11): 2059-2069.

18.

McDonald WI , Compston A. , Edan G. , et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127.

19.

Kozak M. An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 1987; 15: 8125-8148.

20.

Saiz A. , Zuliani L. , Blanco Y. , Tavolato B. , Giometto B. , Graus F. Revised diagnostic criteria for neuromyelitis optica (NMO). Application in a series of suspected patients. J Neurol 2007 ; 254: 1233-1237.

21.

Tanaka K. , Tani T. , Tanaka M. , et al. Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions. Mult Scler 2007; 13: 850-855.

22.

Kuhle J. , Pohl C. , Mehling M. , et al. Lack of association between antimyelin antibodies and progression to multiple sclerosis. N Engl J Med 2007; 356: 371-378.

23.

Schmidli RS , Colman PG , Bonifacio E. Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. The Second International GADAB Workshop. Diabetes 1995; 44: 636-640.

24.

Nicchia GP , Mastrototaro M. , Rossi A. , et al. Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies. Glia 2009.

25.

Bingley PJ , Bonifacio E. , Mueller PW Diabetes Antibody Standardization Program: first assay proficiency evaluation . Diabetes 2003; 52: 1128-1136.

26.

Torn C. , Mueller PW , Schlosser M. , Bonifacio E. , Bingley PJ Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2. Diabetologia 2008; 51: 846-852.

27.

Hayakawa S. , Mori M. , Okuta A. , et al. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay. J Neuroimmunol 2008; 196: 181-187.